Tag Archives: CIPLA

Pharmaceutical firm hopes to recover in second half of the year Kampala, Uganda | ISAAC KHISA | Cipla Quality Chemicals Industries Ltd has recorded a decline in profit since it was listed on the Uganda Securities Exchange a year ago but its managers are now pinning its growth prospects on …

As its profit after tax drop more than seven times to Shs 6.8bn in 2018 Kampala, Uganda | ISAAC KHISA | The Kampala-based pharmaceutical firm, Cipla Quality Chemical Industries Ltd has hinted on a move to acquire a small company to boost its business growth. This comes at a time …

Company’s IPO was the most efficient with less than 5% of advertising and promotional budget compared to previous offers Kampala, Uganda | JULIUS BUSINGE | Shares of Cipla Quality Chemicals Ltd started trading at the Uganda Securities Exchange on September 17, making it the first drug maker in the region to …

Kampala, Uganda | ISAAC KHISA | Drug manufacturing firm, Cipla Quality Chemical Industries Limited, hopes to raise at least Shs168.56bn through an Initial Public Offer that opened on August 14-24. The firm that is 62.3% owned by India’s Cipla, is offering 657.17million shares at a cost of Shs 256.5 per share. …

Analysts anticipate some buzz on market that last had listing in 2012 Kampala, Uganda | JULIUS BUSINGE | Uganda’s Securities Exchange market is set to experience some new buzz again as the long awaited drug maker, Cipla Quality Chemical Industries Ltd (CiplaQCIL), makes an Initial Public Offering this month. The company …

Ugandan bourse managers say pharmaceutical firm’s latest plans no different from past claims The Kampala-based pharmaceutical firm Cipla Quality Chemical Industries Ltd, often called just Quality Chemicals Ltd, has once again signaled intention to offer shares to the public in an Initial Public Offer (IPO). The subsidiary of Indian drugs …

The High Court in Kampala on Wednesday summoned the Attorney General of Government and  National Medical Stores (NMS) to respond to claims that it has continuously withdrawn money from the consolidated fund  to purchase imported  anti-retroviral and anti-malarial drugs from a local manufacturer disguised as locally made. Documents presented to …

NMS, Cipla: Fight over pricing could lead to higher costs for patients and the government  “NO ARVs means death.” That shocking but true fact was stated by Joshua Wamboga, the head of the Uganda Network of AIDS Service Organisations (UNASO) in January when Uganda was reeling from a major stock-out …